Question
Discuss the laboratory diagnosis of mycetoma
Answer
Mycetoma is a chronic, slowly progressive granulomatous infection of the subcutaneous tissue, most often affecting the foot (“Madura foot”), caused either by true fungi (eumycetoma) or by filamentous, aerobic actinomycete bacteria (actinomycetoma) — distinguishing between the two is essential, since treatment differs completely (antifungal versus antibacterial therapy).
Clinical presentation: a triad of tumefaction (swelling), multiple sinus tracts, and discharge containing grains (granules) — the colour, size, and consistency of these grains provide an important diagnostic clue to the causative organism.
Laboratory diagnosis:
- Direct examination of grains — grains expressed from a discharging sinus (or obtained by deep surgical biopsy, preferred over superficial swab to avoid contamination) are washed, crushed between two slides, and examined microscopically:
- Eumycetoma (true fungi, e.g., Madurella mycetomatis) — grains typically black or dark-coloured, show broad, septate fungal hyphae on microscopy.
- Actinomycetoma (aerobic actinomycetes, e.g., Nocardia, Actinomadura, Streptomyces species) — grains typically white, yellow, or red, show fine, thin, branching filaments (bacterial, much narrower than fungal hyphae) on microscopy, sometimes with a surrounding Splendore-Hoeppli reaction.
- Histopathology — biopsy of the sinus tract/grain shows the grain surrounded by a dense neutrophilic infiltrate and granulomatous inflammation; special stains (PAS, Gomori methenamine silver for fungi; Gram/modified acid-fast for actinomycetes) help distinguish the two categories and identify individual organisms.
- Culture — grains are cultured on appropriate media (Sabouraud dextrose agar for fungi; specific media for actinomycetes) to identify the specific causative species, essential for guiding precise therapy, though growth can be slow.
- Imaging (X-ray, ultrasound, MRI) — assesses extent of bone involvement/destruction, useful for staging and surgical planning.
- Molecular methods (PCR, sequencing) — increasingly used, especially where culture is difficult, slow, or inconclusive.
Clinical significance of distinguishing eumycetoma from actinomycetoma: actinomycetoma generally responds well to prolonged combination antibacterial therapy (e.g., a sulfonamide-based regimen combined with an aminoglycoside), whereas eumycetoma requires antifungal therapy (e.g., itraconazole) often combined with surgical excision, and generally has a poorer prognosis and higher recurrence rate — making accurate microbiological distinction essential for appropriate management.